Cellectis GAAP EPS of -$0.63 misses by $0.14, revenue of $1.92M

• Cellectis press release (NASDAQ:CLLS): Q3 GAAP EPS of -$0.63 misses by $0.14.
• Revenue of $1.92M (-82.3% Y/Y).
• As of September 30, 2022, Cellectis, including Calyxt, had $103 million in consolidated cash, cash equivalents, and restricted cash of which $95 million are attributable to Cellectis on a stand-alone basis.